Bisker-Leib Vered
Insider CIK 1814093 · ADXS Director · NONE President & COO, Director · AYLA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2024-02-08 | 2024-02-09 | 49,198 | $1.45 | $71.3K | 3,124,426 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2024-01-09 | 2024-01-10 | 1,753,125 | — | $0 | 1,753,125 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award | 2024-01-09 | 2024-01-10 | 1,753,125 | $1.93 | $3.38M | 3,173,624 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | F Tax w/h | 2023-11-17 | 2023-11-21 | 64,415 | $1.50 | $96.6K | 1,420,499 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2023-02-08 | 2023-02-09 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award | 2023-02-08 | 2023-02-09 | 400,000 | — | $0 | 1,484,914 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 1,171 | — | $0 | 1,171 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 1,171 | — | $0 | 1,171 | SEC↗ |
| ADXS Ayala Pharmaceuticals, Inc | A Award deriv | 2023-01-19 | 2023-01-23 | 1,639 | — | $0 | 1,639 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 8,750 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2022-11-25 | 2022-11-25 | 2 | $4.36 | $9 | 1,060,414 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2022-11-23 | 2022-11-25 | 9,569 | $4.30 | $41.1K | 1,060,416 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2022-11-22 | 2022-11-25 | 14,929 | $4.19 | $62.6K | 1,069,985 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2022-11-21 | 2022-11-22 | 16,035 | $4.34 | $69.6K | 1,084,914 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | S Sale | 2022-11-18 | 2022-11-22 | 6,226 | $4.40 | $27.4K | 1,107,175 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2022-06-13 | 2022-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-02-18 | 2022-02-23 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-02-17 | 2022-02-18 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award | 2021-11-16 | 2021-11-18 | 600,000 | — | $0 | 1,113,401 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2021-06-10 | 2021-06-14 | 6,250 | — | $0 | 6,250 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2021-02-09 | 2021-03-01 | 400,000 | — | $0 | 400,000 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2020-08-18 | 2020-08-20 | 8,750 | — | $0 | 8,750 | SEC↗ |
| NONE Compass Therapeutics, Inc. | A Award deriv | 2020-08-06 | 2020-08-10 | 600,000 | — | $0 | 600,000 | SEC↗ |